Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The ventricular assist device patient.

M R Cleavinger1, R G Smith

  • 1University Medical Center, Tucson, AZ 85724.

Journal of Health Care Chaplaincy
|December 9, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.

Journal of neurochemistry·1998
Same author

Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients.

Annals of neurology·1998
Same author

Infections with the CardioWest total artificial heart.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·1998
Same author

Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors.

Genomics·1998
Same author

Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.

Science (New York, N.Y.)·1998
Same author

Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.

Annals of neurology·1998
Same journal

Conceptualizing spiritual care in the U.S. through chaplain activities in research: a scoping review sub-analysis.

Journal of health care chaplaincy·2026
Same journal

What medical students learn from shadowing chaplains.

Journal of health care chaplaincy·2026
Same journal

The Family Perspectives Project: development and preliminary feasibility of a chaplain-delivered emotional support intervention for families of critically ill patients.

Journal of health care chaplaincy·2026
Same journal

Hope in providing spiritual care together: a qualitative study among chronically ill patients, chaplains, general practitioners and nurses.

Journal of health care chaplaincy·2026
Same journal

Beyond the frontlines: examining healthcare chaplains' experiences of workplace violence.

Journal of health care chaplaincy·2026
Same journal

Understanding a multisensory program toward workforce well-being and care quality in a pediatric hospital: a cross-sectional survey.

Journal of health care chaplaincy·2026
See all related articles

Ventricular assist devices (VADs) support heart function and recovery. Adapting to VADs involves managing quality of life, complications, and mobility, with caregivers playing a vital role.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Patient Care

Background:

  • Ventricular assist devices (VADs) are mechanical pumps circulating blood.
  • Current uses include bridging to heart transplantation and supporting cardiac recovery.
  • Permanent VAD implantation is an emerging possibility.

Purpose of the Study:

  • To provide an overview of ventricular assist devices.
  • To discuss the impact of VADs on recipients' lives and adaptation.
  • To present topics related to patient adjustment and care.

Main Methods:

  • Literature review and synthesis of current knowledge on VADs.
  • Discussion of patient adjustment processes and quality of life issues.
  • Exploration of the role of caregivers in VAD patient support.

Related Experiment Videos

Main Results:

  • VADs significantly impact recipients' lives, necessitating adaptation.
  • Key adjustment issues include optimizing patient care, managing complications, and addressing mobility limitations.
  • Caregiver support is crucial for meeting patients' physical, emotional, and spiritual needs.

Conclusions:

  • VAD technology offers significant therapeutic potential but presents adaptation challenges.
  • Addressing quality of life, complications, and mobility is essential for successful VAD use.
  • Integrated care involving patients, caregivers, and healthcare providers is vital for optimal outcomes.